This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tianyin Pharmaceutical's CEO Discusses FQ3 2011 Results - Earnings Call Transcript

Tianyin Pharmaceutical Co., Inc. ( TPI)

FQ3 2011 Earnings Call

May 17, 2011 9:00 am ET

Executives

James Jiayuan Tong – Chief Financial Officer and Chief Business & Development Officer

Analysts

Adam Waldo – Lismore Partners LLC

Angel Liu – Pope Asset Management

Iao Kiagra – Private Investor

Presentation

Operator

Good morning ladies and gentlemen and thank you for standing by. Welcome to the Tianyin Pharmaceutical Incorporated FQ3 2011 Earnings Conference Call.

(Operator instructions.)

And at this time I would now like to turn the conference over to Dr. James Tong who is the Chief Financial Officer. Please go ahead sir.

James Jiayuan Tong

Thank you operator. Good morning, good evening ladies and gentlemen. Welcome to Tianyin Pharmaceutical TTI FQ3 2011 Earnings Conference Call. I am James Jiayuan Tong, Chief Financial Officer and Chief Business Development Officer of TTI along with Simon Min Ren, Director of Investor Relation and Meinian Yuan, Assistant to CFO. We haven’t connected with Dr. Guoqing, CEO and Chairman of the company because he is on the road at the moment and so far the signal connection has not been restored.

During this conference call we will be reviewing the FQ3 2011 financial highlights followed by the question and answer period. Before we continue please know that this call will contain forward-looking statements made under the Safe Harbor provisions of the US Private Security Litigation Reform Act of 1995.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs